These guidelines have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines and a brief overview of epidemiolo
Treatment of bullous pemphigoid: what's new?
โ Scribed by U Wollina
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 52 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0926-9959
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The presence of circulating basement membrane zone (BMZ) antibodies is characteristic of patients with bullous pemphigoid (BP) and are routinely employed in making the diagnosis. The positive tests, however, occur in 50-70% of patients with BP, thus necessitating consideration of other tests in a si
The status of clinical drug trials is reviewed along with how these experimental protocols have influenced treatment for HIV and AIDS.
Pemphigoid nodularis is a rare clinical variant of pemphigoid characterized by overlapping clinical features of both prurigo nodularis lesions and pemphigoid-like blisters. In pemphigoid nodularis, the immunopathological findings are identical to those of bullous pemphigoid (BP). We describe five pa